Cancer vaccines development has been intensively pursued over the past half decade with moderate success. However, recent advancements in the fields of molecular biology, genetics, biochemistry, and immunology have renewed interest and allowed the development of promising cancer vaccine candidates.
Major factors driving the cancer vaccine market growth include the increasing number of cancer cases, rising investments and funding by government organizations for developing cancer vaccines, and technological developments in cancer vaccines platforms.